The mobile gamma cameras market is likely to remain growing through the coming decade due to rising demands for flexible, point-of-care diagnostic solutions. It is thought that the rise will go from a price of USD 64.6 billion in 2025 to USD 100.3 billion by 2035. This marks a growth rate of 4.5% for the years 2025 to 2035.
Mobile gamma cameras refer to portable devices used in nuclear medicine to perform imaging procedures such as Single Photon Emission Computed Tomography (SPECT) scans. They may be useful in various clinical settings by offering patients flexibility for in-house, outpatient, or even home-based diagnosis. Growth in access and better results for patients would continue to fuel the adoption of mobile gamma cameras among healthcare providers.
Market Metrics
| Metric | Value |
|---|---|
| Market Size (2025E) | USD 64.6 Billion |
| Market Value (2035F) | USD 100.3 Billion |
| CAGR (2025 to 2035) | 4.5% |
The North America region is projected to acquire a considerable segment of the mobile gamma cameras' market owing to its modern healthcare infrastructural facilities, the growing incidence of chronic diseases, and an increasing demand for portable diagnostic devices anytime, anywhere.
Notably, among others, the USA is a strong component in adopting mobile gamma cameras into the healthcare provider settings to improve access and patient care, particularly in remote or underserved areas. Furthermore, the region's continued coverage in favour of healthcare innovation and technological advancements will spur growth in the market continuously.
Mobility gamma cameras hold an important part of the market in Europe, with Germany, France, and the United Kingdom in need of mobile nuclear medicine solutions. Obviously, the demographic trends of an aging population along with the need for advanced diagnostic technology will increase the commercial thrust for mobile gamma cameras. Additionally, growing awareness of mobile diagnostics benefits and national initiatives toward an efficient healthcare delivery system will complement market expansion.
Asia Pacific has enormous maturation expertise in the mobile gamma camera market, supported by improvements in healthcare infrastructure, refining healthcare payment, and growing demand for modern diagnostic technologies in China, India, and Japan. The rising middle-class population and growing prevalence of chronic diseases in the region will thereby drive the demand for mobile gamma cameras as easy to reach and cost-productive diagnostic cures.
Cost and Regulatory Approvals
Mobile gamma cameras certainly have plus points, but high pricing of the devices and their stringent regulations would make commercialization difficult, especially in the emerging markets. Furthermore, in certain areas, market penetration could be delayed because these devices require special training to operate and regulatory approval processes for medical devices are rather complicated.
Technological Advancements and Expansion of Healthcare Services
The integration of advanced technologies such as artificial intelligence (AI) and machine learning (ML) into mobile gamma cameras would probably enhance diagnostic accuracy and the user experience, thus creating substantial market growth opportunities.
Concurrently, another opportunity for market growth for mobile gamma cameras is provided by the mounting demand for personalized and homebased healthcare services, particularly in homecare and outpatient settings. With the greater emphasis on economical and portable solutions, mobile gamma camera market trends would benefit.
The mobile gamma cameras market will become favoured to grow repeatedly from 2025 to 2035 due to increased demand for nuclear imaging methods in physical state care and growing needs for portable diagnostic facilities, which is a critical angle of today's medicine.
Non-invasive diagnostic imaging is accomplished by using mobile gamma cameras that are very important in nuclear medicine for the purpose of transportable and flexible workplaces. Such imaging results are primarily applied for oncology, cardiology, and neurology, although such cameras can view patients in emergency departments and outpatient facilities.
Adoption has been enhanced with newer technology including detector sensitivity improvements, greater image resolution, and assembly of smaller, cost-effective portable gamma cameras, allowing diagnostic scans under numerous environments and less reliance on fixed imaging facilities with quicker on-the-go imaging.
Market Shifts: 2020 to 2024 vs. 2025 to 2035
| Key Dimensions | 2020 to 2024 |
|---|---|
| Growth Drivers | Rising demand for mobile diagnostics, increase in nuclear imaging |
| Technology Trends | Portable imaging systems, enhanced gamma detectors |
| Application Focus | Oncology, cardiology, emergency care |
| End-User Adoption | Hospitals, outpatient clinics, emergency medical services |
| Geographic Demand | North America, Europe, Asia-Pacific |
| Regulatory Landscape | Regulatory standards for medical imaging equipment |
| Innovation Focus | Enhanced mobility, user-friendly interfaces |
| Supply Chain Dynamics | Centralized supply chains, limited production volume |
| Key Dimensions | 2025 to 2035 |
|---|---|
| Growth Drivers | Aging population, growth in outpatient diagnostics, telemedicine adoption |
| Technology Trends | Compact, high-resolution detectors, AI-powered diagnostics, real-time imaging |
| Application Focus | Expanded use in neurology, sports injuries, rural healthcare, point-of-care |
| End-User Adoption | Home healthcare, remote clinics, outpatient care centers, global healthcare networks |
| Geographic Demand | Rapid growth in emerging markets, continued adoption in developed regions |
| Regulatory Landscape | Stronger focus on mobile healthcare technology regulations, remote imaging standards |
| Innovation Focus | Integration with mobile health apps, cloud storage, real-time reporting |
| Supply Chain Dynamics | Expansion in global manufacturing capabilities, local production in emerging markets |
The mobile gamma cameras marketin the United States continues to grow continually owing to progressing demand for non-invasive diagnostic imaging and fastly developing mobile healthcare options. The presence of gigantic progress in mobile imaging technologies, coupled with the moment of on-site diagnostics, particularly in rural and underserved areas makes the USA market entirely great. Increased healthcare spending and a rising number of chronic diseases drive the spreading of mobile gamma cameras.
| Country | CAGR (2025 to 2035) |
|---|---|
| United States | 4.8% |
In the UK, the growth of the mobile gamma cameras marketis said to be moderate since the facility of mobile imaging systems has been integrated into the hospitals and clinics, thereby making the whole process of diagnosis an easy pastime.
The investment by the NHS in mobile health technologies and the growing focus on point-of-care diagnostics further trigger this technology adoption. The other reasons that will drive their demand are the increasing geriatric population and cases of cancer.
| Country | CAGR (2025 to 2035) |
|---|---|
| United Kingdom | 4.4% |
The European Union mobile gamma cameras market is primed for moderate growth especially in Germany and France where great emphasis is placed on enhancing means of access to healthcare using mobile diagnostic solutions.
Growing awareness regarding the use of mobile imaging for early detection of diseases, in particular cancer, is driving the demand. Also, government initiatives and healthcare reforms strengthening the adoption of mobile healthcare devices are the other factors contributing to the growth of this market.
| Country | CAGR (2025 to 2035) |
|---|---|
| European Union | 4.7% |
The ongoing expansion of the mobile gamma cameras marketin Japan is being propelled as a continuation of the country's efforts to enhance diagnostic services for all areas, be they urban or remote. Factors such as an increasingly aging population and high prevalence of cardiovascular diseases require imaging solutions to be deployed mobile in the country. In fact, Japan has a sophisticated healthcare infrastructure that is set for supporting the installation of mobile gamma cameras in public and private health facilities.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 4.3% |
The South Korean mobile gamma cameras marketis showing rapid progress, driven by the widespread selection of mobile medical technologies and an interest on manufacturing diagnostic tools more reachable. In distinct, the government's investments in healthcare innovation and rising demand for rushed and distinct diagnostic answers have been speeding up the selection of mobile gamma cameras in hospitals and diagnostic centers. South Korea's cutting-edge healthcare routine promotes this surfacing trend.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 4.6% |
The market for mobile gamma cameras will see tremendous growth by 2025 to 2035 as the emerging trends tend toward the demand for cost-effective and portable diagnostic solutions in healthcare settings. It is an innovative method that is usually more flexible in conducting imaging, particularly in remote areas, where it cannot be conducted with the use of ordinary, stationary imaging equipment. Mobile gamma cameras are essential in performing gamma imaging, and it is commonly used for diagnosing many medical conditions such as cardiac, breast, and brain disorders.
Single Head Mobile Gamma Cameras to Lead the Market
| Product Type | Market Share |
|---|---|
| Single Head | 38.2% |
Single-head portable gamma cameras would lead the market in 2025 with a 38.2% market share. These devices are ideal for small hospitals and outpatient facilities as they are compact, inexpensive, and easy to use; they are well-equipped to carry out mobile health units as well. They can come in very handy in routine diagnostic tasks and in those settings with space and funding constraints.
Distant from the financial viability, advantages of operation, and lightweight forms of being possible imaging performative fulfilling fundamental topics falling within a broad spectrum of clinical settings, the interests for Single Head mobile gamma cameras include improving radiology departments' accuracy without the need for extensive capital investment.
Cardiac Imaging to Capture the Largest Share
| Indication | Market Share |
|---|---|
| Cardiac Imaging | 40.4% |
In 2025, it would be expected that the largest share was due to Cardiac Imaging which accounted for 40.4%. Mobile gamma cameras used for cardiac imaging are widely available, especially in diagnosing and evaluating coronary artery disease and heart function. These devices allow imaging at different places, which make a difference for patients who may find it difficult to travel to conventional imaging centers.
The increasing number of cardiovascular patients in the world is one major driver of the demand for the Cardiac Imaging market via mobile gamma cameras. Portability has allowed more frequent testing, especially in emergency care or ambulatory situations, where time is of utmost importance for patient outcomes. Mobile healthcare solutions further tend to grow this demand, especially for mobile gamma cameras.
The mobile gamma cameras market is expected to grow tremendously in the years to come, especially from 2025 to 2035, as advanced diagnostic imaging solutions are highly demanded across urban and rural healthcare facilities.
These cameras are important imaging instruments for nuclear medicine, including applications such as single photon emission computed tomography (SPECT) scans, and given the portable and flexible nature of the imaging, that would thereby enable all these providers to perform top-notch diagnostics in all different settings.
Some of the significant motivating driving forces will be advancements in sensitivity, portability, and cost-efficiency in gamma camera technology. The mobile gamma cameras will be widely used across healthcare environments such as outpatient clinics, emergency care, and rural areas with limited healthcare infrastructure and thus are expected to see increased uptake. The company is directly working on improving healthcare access through its government initiatives; increasing prevalence of chronic disease incidences is also part of the demands for these devices.
Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| Siemens Healthineers | 25-30% |
| GE Healthcare | 18-22% |
| Philips Healthcare | 15-18% |
| Canon Medical Systems | 10-12% |
| Mediso Ltd. | 7-9% |
| Other Companies (combined) | 22-28% |
| Company Name | Key Offerings/Activities |
|---|---|
| Siemens Healthineers | In 2024, Siemens launched an upgraded mobile gamma camera with enhanced spatial resolution and a more compact design for improved portability. In 2025, it plans to integrate AI-powered analysis for faster diagnosis. |
| GE Healthcare | GE introduced a mobile gamma camera in 2024 with advanced data analysis tools and integration capabilities with hospital information systems. For 2025, GE aims to enhance battery life and mobile connectivity. |
| Philips Healthcare | Philips rolled out a next-gen mobile gamma camera system in 2024 featuring a lightweight design and real-time imaging capabilities. In 2025, it plans to expand its product line with a focus on affordability for smaller healthcare centers. |
| Canon Medical Systems | Canon’s 2024 mobile gamma camera features increased sensitivity for early cancer detection, with a focus on customizable imaging protocols. For 2025, Canon intends to improve wireless connectivity and patient data integration. |
| Mediso Ltd. | In 2024, Mediso launched a mobile SPECT system that offers both diagnostic imaging and therapeutic capabilities, targeting markets with high demand for flexible diagnostic tools. In 2025, it plans to expand its user-friendly interface and optimize for remote diagnostics. |
Key Company Insights
Siemens Healthineers (25-30%)
Siemens is a leader in the mobile gamma camera market, known for its high-performance diagnostic imaging systems. With advanced image quality and cutting-edge AI integration, Siemens caters to hospitals and outpatient settings that require portable, reliable nuclear medicine imaging solutions.
GE Healthcare (18-22%)
GE Healthcare has made significant strides with its mobile gamma camera systems, offering high-resolution imaging and advanced connectivity. The company’s devices are commonly deployed in emergency settings and remote healthcare locations.
Philips Healthcare (15-18%)
Philips offers highly portable gamma cameras that are easy to operate, making them ideal for use in small clinics and rural healthcare settings. Philips emphasizes affordability while maintaining high-quality diagnostic capabilities.
Canon Medical Systems (10-12%)
Canon’s mobile gamma cameras are favored for their superior sensitivity and customizable imaging features, targeting markets that need both portability and advanced imaging quality. Canon’s focus is on early cancer detection and personalized diagnostic approaches.
Mediso Ltd. (7-9%)
Mediso’s mobile SPECT systems are designed to offer both diagnostic and therapeutic solutions, allowing for comprehensive treatment management. The company’s growth is driven by its focus on user-friendly, flexible equipment for smaller healthcare providers.
Other Key Players (22-28% Combined)
The overall market size for the mobile gamma cameras market was USD 64.6 billion in 2025.
The market is expected to reach USD 100.3 billion in 2035.
Demand will be driven by the increasing adoption of mobile diagnostic imaging technologies, the growing prevalence of cardiovascular diseases and cancer, the need for cost-effective and portable imaging solutions, and technological advancements in gamma camera systems.
The top 5 contributing countries are the United States, Germany, Japan, China, and the United Kingdom.
The portable gamma camera segment is expected to lead due to its flexibility, ease of use in various clinical settings, and growing demand for point-of-care diagnostics.
Explore Diagnostic Devices Insights
Mobile Gamma Cameras Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
